Lab Information

Peter Lakatos (MD)

Clinical Research Unit
Department of Medicine (McGill)

Research Profile

 Fundamental: 0%
 Clinical: 50%
 Epidemiology: 0%
 Evaluation: 50%
 This email address is being protected from spambots. You need JavaScript enabled to view it.


Inflammatory bowel diseases (IBD) • gastroenterology • colitis • Crohn’s disease

Team Members

Name Position

Latest Publications

  1. Wetwittayakhlang, P., Al Khoury, A., Hahn, G. D. & Lakatos, P. L. (2022). The Optimal Management of Fistulizing Crohn's Disease: Evidence beyond Randomized Clinical Trials. Journal of clinical medicine, vol. 11.
  2. Hahn, G. D., Wetwittayakhlang, P., Afif, W., Bessissow, T. & Lakatos, P. L. (2022). Hereditary Nonpolyposis Colorectal Cancer in Association with Crohn's Disease and Lynch Syndrome: The Importance of a Strict Endoscopic Surveillance. Case reports in gastroenterology, vol. 16, p. 116-121.
  3. Hahn, G. D., Golovics, P. A., Wetwittayakhlang, P., Al Khoury, A., Bessissow, T. & Lakatos, P. L. (2022). Is There a Best First Line Biological/Small Molecule in IBD: Are We Ready for Sequencing?. Biomedicines, vol. 10.
  4. Garza-Hernandez, D., Sepulveda-Villegas, M., Garcia-Pelaez, J., Aguirre-Gamboa, R., Lakatos, P. L., Estrada, K., Martinez-Vazquez, M. & Trevino, V. (2022). A systematic review and functional bioinformatics analysis of genes associated with Crohn's disease identify more than 120 related genes. BMC genomics, vol. 23, p. 302.
  5. Xiao, Y., Benoit, N., Sedano, R., Jairath, V., Narula, N., McCurdy, J. D., Rosenfeld, G., Afif, W., Lakatos, P. L. & Bessissow, T. (2022). Effectiveness of Tofacitinib for Hospitalized Patients with Acute Severe Ulcerative Colitis: Case Series. Digestive diseases and sciences.
  6. Caron, B., Abreu, M. T., Siegel, C. A., Panaccione, R., Sands, B. E., Dignass, A., Turner, D., Dotan, I., Hart, A. L., Ahuja, V., Allez, M., Ananthakrishnan, A. N., Ghosh, S., Griffiths, A. M., Halfvarson, J., Kaser, A., Kotze, P. G., Koutroubakis, I. E., Lakatos, P. L., Levine, A., Lewis, J. D., Magro, F., Mantzaris, G. J., O'Morain, C., Ran, Z., Reinisch, W., Rogler, G., Sachar, D. B., Siegmund, B., Silverberg, M. S., Sood, A., Spinelli, A., Steinwurz, F., Tysk, C., Yamamoto-Furusho, J. K., Schreiber, S., Rubin, D. T., Sandborn, W. J., Danese, S. & Peyrin-Biroulet, L. (2022). IOIBD Recommendations for Clinical Trials in Ulcerative Proctitis: the PROCTRIAL Consensus. Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
  7. Golovics, P. A., Verdon, C., Wetwittayakhlang, P., Filliter, C., Gonczi, L., Hahn, G. D., Wild, G. E., Afif, W., Bitton, A., Bessissow, T., Brassard, P. & Lakatos, P. L. (2022). Increased Prevalence of Myocardial Infarction and Stable Stroke Proportions in Patients with Inflammatory Bowel Diseases in Quebec in 1996-2015. Journal of clinical medicine, vol. 11.
  8. Guillo, L., Abreu, M., Panaccione, R., Sandborn, W. J., Azevedo, V. F., Gensler, L., Moghaddam, B., Ahuja, V., Ali, S. A., Allez, M., Ananthakrishnan, A. N., Bhattacharya, A., Dubinsky, M., Griffiths, A., Hart, A., Korelitz, B., Kotze, P. G., Koutroubakis, I. E., Lakatos, P. L., Lindsay, J. O., Magro, F., Mantzaris, G. J., Ng, S. C., O'Morain, C., Panés, J., Parigi, T., Ran, Z., Rogler, G., Rubin, D. T., Sachar, D. B., Siegmund, B., Steinwurz, F., Tysk, C., Vavricka, S., Verstraete, S. G., Brezin, A. P., Haemel, A. K., Dignass, A., Sands, B. E., Danese, S. & Peyrin-Biroulet, L. (2022). Endpoints for extraintestinal manifestations in inflammatory bowel disease trials: the EXTRA consensus from the International Organization for the Study of Inflammatory Bowel Diseases. The lancet. Gastroenterology & hepatology, vol. 7, p. 254-261.
  9. Isnard, S., Fombuena, B., Ouyang, J., Royston, L., Lin, J., Bu, S., Sheehan, N., Lakatos, P. L., Bessissow, T., Chomont, N., Klein, M., Lebouché, B., Costiniuk, C. T., Routy, B., Marette, A., Routy, J.-P. & Camu Camu Study Group (2022). Camu Camu effects on microbial translocation and systemic immune activation in ART-treated people living with HIV: protocol of the single-arm non-randomised Camu Camu prebiotic pilot study (CIHR/CTN PT032). BMJ open, vol. 12, p. e053081.
  10. Wetwittayakhlang, P., Lontai, L., Gonczi, L., Golovics, P. A., Hahn, G. D., Bessissow, T. & Lakatos, P. L. (2021). Treatment Targets in Ulcerative Colitis: Is It Time for All In, including Histology?. Journal of clinical medicine, vol. 10.
More on PubMed 

See also

Card image

See profile
Card image

See profile
Card image

See profile
Card image

See profile
Card image

See profile
Card image

See profile